Current and projected number of years of life lost due to prostate cancer: A global study
Background Prostate cancer is an important cause of death worldwide. The number of years of life lost (YLL) due to prostate cancer is a metric of the toll of prostate cancer and using projections of demographic changes, can be used to measure future burden. Methods Prostate cancer mortality data by...
Uložené v:
| Vydané v: | The Prostate Ročník 82; číslo 11; s. 1088 - 1097 |
|---|---|
| Hlavní autori: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Wiley Subscription Services, Inc
01.08.2022
|
| Predmet: | |
| ISSN: | 0270-4137, 1097-0045, 1097-0045 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background
Prostate cancer is an important cause of death worldwide. The number of years of life lost (YLL) due to prostate cancer is a metric of the toll of prostate cancer and using projections of demographic changes, can be used to measure future burden.
Methods
Prostate cancer mortality data by country and world region was retrieved from the Global Cancer Observatory and the World Health Organization mortality data set, and life expectancy was from the United Nations Department of Economic and Social Affairs. We estimated YLL as the difference between age at death in people with prostate cancer and remaining life expectancy for people of the same age in the general population. We also estimated the age‐standardized YLL rates per 100,000 males over 50 and the average annual percentage change in YLL rates over the period 2000–2019 and the number of YLL for the year 2040 by applying population projections to the 2020 YLL rates.
Results
In 2020, 3.5 million person‐years of life were lost due to prostate cancer in males over 50, and 40% of YLL were in those aged over 75. Age‐standardized rates varied greatly between and within regions. Over the last two decades, rates of YLL have increased in many Asian and African countries while they have decreased in northern American and European countries. Globally, YLL are anticipated to double by 2040 to reach 7.5 million, with the greatest increases in Africa, Asia, and Latin America and the Caribbean.
Conclusion
There are wide variations in the burden of prostate cancer globally as measured by YLL. The burden of prostate cancer is projected to increase over time and appears to be highest in Sub‐Saharan Africa, Eastern Europe, and Latin America and the Caribbean. It will be critical to plan and implement programs to reduce the burden of prostate cancer globally. |
|---|---|
| AbstractList | Prostate cancer is an important cause of death worldwide. The number of years of life lost (YLL) due to prostate cancer is a metric of the toll of prostate cancer and using projections of demographic changes, can be used to measure future burden.BACKGROUNDProstate cancer is an important cause of death worldwide. The number of years of life lost (YLL) due to prostate cancer is a metric of the toll of prostate cancer and using projections of demographic changes, can be used to measure future burden.Prostate cancer mortality data by country and world region was retrieved from the Global Cancer Observatory and the World Health Organization mortality data set, and life expectancy was from the United Nations Department of Economic and Social Affairs. We estimated YLL as the difference between age at death in people with prostate cancer and remaining life expectancy for people of the same age in the general population. We also estimated the age-standardized YLL rates per 100,000 males over 50 and the average annual percentage change in YLL rates over the period 2000-2019 and the number of YLL for the year 2040 by applying population projections to the 2020 YLL rates.METHODSProstate cancer mortality data by country and world region was retrieved from the Global Cancer Observatory and the World Health Organization mortality data set, and life expectancy was from the United Nations Department of Economic and Social Affairs. We estimated YLL as the difference between age at death in people with prostate cancer and remaining life expectancy for people of the same age in the general population. We also estimated the age-standardized YLL rates per 100,000 males over 50 and the average annual percentage change in YLL rates over the period 2000-2019 and the number of YLL for the year 2040 by applying population projections to the 2020 YLL rates.In 2020, 3.5 million person-years of life were lost due to prostate cancer in males over 50, and 40% of YLL were in those aged over 75. Age-standardized rates varied greatly between and within regions. Over the last two decades, rates of YLL have increased in many Asian and African countries while they have decreased in northern American and European countries. Globally, YLL are anticipated to double by 2040 to reach 7.5 million, with the greatest increases in Africa, Asia, and Latin America and the Caribbean.RESULTSIn 2020, 3.5 million person-years of life were lost due to prostate cancer in males over 50, and 40% of YLL were in those aged over 75. Age-standardized rates varied greatly between and within regions. Over the last two decades, rates of YLL have increased in many Asian and African countries while they have decreased in northern American and European countries. Globally, YLL are anticipated to double by 2040 to reach 7.5 million, with the greatest increases in Africa, Asia, and Latin America and the Caribbean.There are wide variations in the burden of prostate cancer globally as measured by YLL. The burden of prostate cancer is projected to increase over time and appears to be highest in Sub-Saharan Africa, Eastern Europe, and Latin America and the Caribbean. It will be critical to plan and implement programs to reduce the burden of prostate cancer globally.CONCLUSIONThere are wide variations in the burden of prostate cancer globally as measured by YLL. The burden of prostate cancer is projected to increase over time and appears to be highest in Sub-Saharan Africa, Eastern Europe, and Latin America and the Caribbean. It will be critical to plan and implement programs to reduce the burden of prostate cancer globally. Prostate cancer is an important cause of death worldwide. The number of years of life lost (YLL) due to prostate cancer is a metric of the toll of prostate cancer and using projections of demographic changes, can be used to measure future burden. Prostate cancer mortality data by country and world region was retrieved from the Global Cancer Observatory and the World Health Organization mortality data set, and life expectancy was from the United Nations Department of Economic and Social Affairs. We estimated YLL as the difference between age at death in people with prostate cancer and remaining life expectancy for people of the same age in the general population. We also estimated the age-standardized YLL rates per 100,000 males over 50 and the average annual percentage change in YLL rates over the period 2000-2019 and the number of YLL for the year 2040 by applying population projections to the 2020 YLL rates. In 2020, 3.5 million person-years of life were lost due to prostate cancer in males over 50, and 40% of YLL were in those aged over 75. Age-standardized rates varied greatly between and within regions. Over the last two decades, rates of YLL have increased in many Asian and African countries while they have decreased in northern American and European countries. Globally, YLL are anticipated to double by 2040 to reach 7.5 million, with the greatest increases in Africa, Asia, and Latin America and the Caribbean. There are wide variations in the burden of prostate cancer globally as measured by YLL. The burden of prostate cancer is projected to increase over time and appears to be highest in Sub-Saharan Africa, Eastern Europe, and Latin America and the Caribbean. It will be critical to plan and implement programs to reduce the burden of prostate cancer globally. BackgroundProstate cancer is an important cause of death worldwide. The number of years of life lost (YLL) due to prostate cancer is a metric of the toll of prostate cancer and using projections of demographic changes, can be used to measure future burden.MethodsProstate cancer mortality data by country and world region was retrieved from the Global Cancer Observatory and the World Health Organization mortality data set, and life expectancy was from the United Nations Department of Economic and Social Affairs. We estimated YLL as the difference between age at death in people with prostate cancer and remaining life expectancy for people of the same age in the general population. We also estimated the age‐standardized YLL rates per 100,000 males over 50 and the average annual percentage change in YLL rates over the period 2000–2019 and the number of YLL for the year 2040 by applying population projections to the 2020 YLL rates.ResultsIn 2020, 3.5 million person‐years of life were lost due to prostate cancer in males over 50, and 40% of YLL were in those aged over 75. Age‐standardized rates varied greatly between and within regions. Over the last two decades, rates of YLL have increased in many Asian and African countries while they have decreased in northern American and European countries. Globally, YLL are anticipated to double by 2040 to reach 7.5 million, with the greatest increases in Africa, Asia, and Latin America and the Caribbean.ConclusionThere are wide variations in the burden of prostate cancer globally as measured by YLL. The burden of prostate cancer is projected to increase over time and appears to be highest in Sub‐Saharan Africa, Eastern Europe, and Latin America and the Caribbean. It will be critical to plan and implement programs to reduce the burden of prostate cancer globally. Background Prostate cancer is an important cause of death worldwide. The number of years of life lost (YLL) due to prostate cancer is a metric of the toll of prostate cancer and using projections of demographic changes, can be used to measure future burden. Methods Prostate cancer mortality data by country and world region was retrieved from the Global Cancer Observatory and the World Health Organization mortality data set, and life expectancy was from the United Nations Department of Economic and Social Affairs. We estimated YLL as the difference between age at death in people with prostate cancer and remaining life expectancy for people of the same age in the general population. We also estimated the age‐standardized YLL rates per 100,000 males over 50 and the average annual percentage change in YLL rates over the period 2000–2019 and the number of YLL for the year 2040 by applying population projections to the 2020 YLL rates. Results In 2020, 3.5 million person‐years of life were lost due to prostate cancer in males over 50, and 40% of YLL were in those aged over 75. Age‐standardized rates varied greatly between and within regions. Over the last two decades, rates of YLL have increased in many Asian and African countries while they have decreased in northern American and European countries. Globally, YLL are anticipated to double by 2040 to reach 7.5 million, with the greatest increases in Africa, Asia, and Latin America and the Caribbean. Conclusion There are wide variations in the burden of prostate cancer globally as measured by YLL. The burden of prostate cancer is projected to increase over time and appears to be highest in Sub‐Saharan Africa, Eastern Europe, and Latin America and the Caribbean. It will be critical to plan and implement programs to reduce the burden of prostate cancer globally. |
| Author | Nikita, Nikita Ferlay, Jacques Rebbeck, Timothy R. Lu‐Yao, Grace Withrow, Diana Sharma, Swapnil Nicholson, Brian Pilleron, Sophie |
| AuthorAffiliation | 5 Dana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, MA 2 Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK 4 Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France 3 Sidney Kimmel Cancer Center, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA 1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK |
| AuthorAffiliation_xml | – name: 5 Dana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, MA – name: 1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK – name: 3 Sidney Kimmel Cancer Center, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA – name: 2 Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK – name: 4 Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France |
| Author_xml | – sequence: 1 givenname: Diana orcidid: 0000-0002-9757-040X surname: Withrow fullname: Withrow, Diana organization: University of Oxford – sequence: 2 givenname: Sophie orcidid: 0000-0001-7146-4740 surname: Pilleron fullname: Pilleron, Sophie organization: University of Oxford – sequence: 3 givenname: Nikita orcidid: 0000-0002-6672-9772 surname: Nikita fullname: Nikita, Nikita organization: Thomas Jefferson University – sequence: 4 givenname: Jacques orcidid: 0000-0003-4927-6932 surname: Ferlay fullname: Ferlay, Jacques organization: Cancer Surveillance Branch, International Agency for Research on Cancer – sequence: 5 givenname: Swapnil surname: Sharma fullname: Sharma, Swapnil organization: Thomas Jefferson University – sequence: 6 givenname: Brian orcidid: 0000-0003-0661-7362 surname: Nicholson fullname: Nicholson, Brian organization: University of Oxford – sequence: 7 givenname: Timothy R. surname: Rebbeck fullname: Rebbeck, Timothy R. organization: Dana‐Farber Cancer Institute and Harvard TH Chan School of Public Health – sequence: 8 givenname: Grace orcidid: 0000-0002-2925-7737 surname: Lu‐Yao fullname: Lu‐Yao, Grace email: grace.luyao@jefferson.edu organization: Thomas Jefferson University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35468227$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kd1rFDEUxYNU7Lb64h8gAV9EmHqTSSYzPghl8QsKFT8efAqZzE2dJZtskxll_3szbi1axKcE7u8c7jn3hByFGJCQxwzOGAB_sUsxn3FRN3CPrBh0qgIQ8oisgCuoBKvVMTnJeQNQcOAPyHEtRdNyrlbk63pOCcNETRhoMdqgnXCgYd72mGh0dI8m5eXjR4fUxzzRYUY6xYXOk5mQWhMsppf0nF752BtP8zQP-4fkvjM-46Ob95R8efP68_pddXH59v36_KKyQrRQtc6ZHmRvyzrg0KBi3SC5dGh7Z1shOyZMaxRvmjKqnQRlB2Gx6YQyXQf1KXl18N3N_RYHW8Ik4_UujVuT9jqaUf89CeM3fRW_646XEtq2GDy7MUjxesY86e2YLXpvAsY5a95IKRvGOC_o0zvoJs4plHiFahkIxZQs1JM_N7pd5XfrBXh-AGypMCd0twgDvZxUL93qXyctMNyB7VhqH-OSZvT_lrCD5Mfocf8fc_3h4-Wng-YnL0e0Kg |
| CitedBy_id | crossref_primary_10_3389_fpubh_2025_1553747 crossref_primary_10_1186_s12894_024_01564_y crossref_primary_10_1371_journal_pone_0310613 crossref_primary_10_1080_1061186X_2024_2418344 crossref_primary_10_3390_cancers17132193 crossref_primary_10_1001_jamainternmed_2025_0316 crossref_primary_10_1111_bju_16120 crossref_primary_10_1002_pros_70028 crossref_primary_10_1007_s10528_025_11079_2 crossref_primary_10_1186_s12301_025_00512_y crossref_primary_10_1186_s12935_023_03084_5 crossref_primary_10_1016_j_euo_2025_04_008 crossref_primary_10_1016_j_eururo_2024_11_013 crossref_primary_10_3390_informatics11020014 crossref_primary_10_3390_pharmaceutics15020662 crossref_primary_10_1186_s12957_022_02812_x crossref_primary_10_1111_bju_15968 crossref_primary_10_3390_plants13071047 crossref_primary_10_1186_s12894_025_01721_x crossref_primary_10_3390_ijms26125630 crossref_primary_10_1016_j_bioorg_2025_108565 crossref_primary_10_1016_j_canep_2024_102570 crossref_primary_10_1016_j_critrevonc_2024_104600 crossref_primary_10_1177_20584601241240318 crossref_primary_10_1002_jbt_23440 crossref_primary_10_1186_s12885_023_11425_w crossref_primary_10_1007_s00508_025_02544_4 crossref_primary_10_3389_fonc_2023_1193736 crossref_primary_10_1186_s12957_022_02807_8 crossref_primary_10_1039_D4MD00302K crossref_primary_10_1038_s41598_025_15038_0 crossref_primary_10_1007_s00604_023_05750_x crossref_primary_10_3390_biomedicines13051182 crossref_primary_10_1007_s00259_025_07448_z crossref_primary_10_1016_j_bioorg_2025_108848 |
| Cites_doi | 10.1200/JCO.2011.35.1916 10.1093/aje/kwx235 10.3322/caac.21660 10.1056/NEJMoa0810084 10.3390/cancers13164169 10.1002/ijc.31937 10.1158/0008-5472.CAN-05-2191 10.1186/s12935-018-0672-2 10.1097/00001648-199007000-00012 10.1016/j.eururo.2019.08.005 10.1038/bjc.2014.364 10.1016/j.jgo.2019.02.014 10.1158/1940-6207.CAPR-11-0354 10.1002/pros.21265 10.1002/ijc.33588 10.1093/ije/dyy254 10.1016/j.juro.2014.04.017 10.1002/pros.24178 10.1038/sj.bjc.6602321 10.1093/jnci/dji065 10.1158/1940-6207.CAPR-10-0229 10.1002/cncr.33818 10.1016/S0140-6736(15)60171-4 10.1002/ijc.30882 10.4103/aja.aja_70_19 10.1016/j.meatsci.2010.04.026 |
| ContentType | Journal Article |
| Copyright | 2022 Wiley Periodicals LLC. |
| Copyright_xml | – notice: 2022 Wiley Periodicals LLC. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 8FD FR3 H94 K9. P64 RC3 7X8 5PM |
| DOI | 10.1002/pros.24360 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-0045 |
| EndPage | 1097 |
| ExternalDocumentID | PMC9246888 35468227 10_1002_pros_24360 PROS24360 |
| Genre | article Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | Caribbean Region Africa Latin America |
| GeographicLocations_xml | – name: Caribbean Region – name: Africa – name: Latin America |
| GrantInformation_xml | – fundername: National Cancer Institute funderid: 5P30CA056036; 5P30CA056036‐19; P20CA233255 – fundername: NCI NIH HHS grantid: P30 CA056036 – fundername: World Health Organization grantid: 001 – fundername: NCI NIH HHS grantid: P20 CA233255 |
| GroupedDBID | --- .3N .GA 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFWVQ AFZJQ AGHNM AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K ROL RX1 RYL SUPJJ SV3 TEORI UB1 V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR XG1 XV2 ZZTAW ~IA ~WT .GJ .Y3 31~ 3O- 53G AANHP AASGY AAYXX ABEML ACBWZ ACRPL ACSCC ACYXJ ADNMO AFFNX AGQPQ AIQQE ASPBG AVWKF AZFZN CITATION EJD FEDTE HF~ HVGLF LW6 M6P O8X PALCI RIWAO RJQFR SAMSI ZGI ZXP CGR CUY CVF ECM EIF NPM 7T5 7TO 8FD FR3 H94 K9. P64 RC3 7X8 5PM |
| ID | FETCH-LOGICAL-c4480-8ffab05bc2270feae719d525fecbfc845914a8a7266e713f507cd4ce6947a9903 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 41 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000787675600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0270-4137 1097-0045 |
| IngestDate | Tue Nov 04 02:06:09 EST 2025 Fri Jul 11 12:16:23 EDT 2025 Sat Nov 29 14:37:55 EST 2025 Mon Jul 21 06:03:38 EDT 2025 Sat Nov 29 01:37:02 EST 2025 Tue Nov 18 22:12:51 EST 2025 Wed Aug 20 07:24:18 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | mortality epidemiology prostate cancer years of life lost |
| Language | English |
| License | 2022 Wiley Periodicals LLC. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4480-8ffab05bc2270feae719d525fecbfc845914a8a7266e713f507cd4ce6947a9903 |
| Notes | Diana Withrow and Sophie Pilleron contributed equally and share first authorship. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 DW and SP designed the study, analysed data, wrote the first version, and reviewed the manuscript. JF provided GCO data and reviewed the manuscript. DW and SP contributed equally and share first authorship. SS contributed to the Introduction of the manuscript. NN, GLY contributed to the discussion section of the manuscript, and reviewed the manuscript. SS, BN and TRR provided feedbacks and reviewed the manuscript. |
| ORCID | 0000-0001-7146-4740 0000-0002-6672-9772 0000-0003-0661-7362 0000-0002-2925-7737 0000-0002-9757-040X 0000-0003-4927-6932 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/9246888 |
| PMID | 35468227 |
| PQID | 2681047175 |
| PQPubID | 1016443 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9246888 proquest_miscellaneous_2655561122 proquest_journals_2681047175 pubmed_primary_35468227 crossref_primary_10_1002_pros_24360 crossref_citationtrail_10_1002_pros_24360 wiley_primary_10_1002_pros_24360_PROS24360 |
| PublicationCentury | 2000 |
| PublicationDate | August 1, 2022 |
| PublicationDateYYYYMMDD | 2022-08-01 |
| PublicationDate_xml | – month: 08 year: 2022 text: August 1, 2022 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Hoboken |
| PublicationTitle | The Prostate |
| PublicationTitleAlternate | Prostate |
| PublicationYear | 2022 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2019; 10 2021; 127 2015; 386 1997 2005; 65 2020; 77 2014; 192 2011; 4 2021; 71 2014; 111 2019; 144 2021; 13 2018; 18 1990; 1 2010; 86 2021 2011; 71 2019; 48 2018 2005; 97 2009; 360 2005; 92 2017; 141 2017; 186 2020; 22 2011; 29 2021; 81 e_1_2_9_11_1 e_1_2_9_10_1 e_1_2_9_13_1 e_1_2_9_12_1 Ferlay J (e_1_2_9_4_1) 2018 e_1_2_9_15_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_18_1 e_1_2_9_20_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_3_1 e_1_2_9_2_1 World Cancer Research Fund (e_1_2_9_19_1) 1997 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 |
| References_xml | – volume: 81 start-page: 825 issue: 12 year: 2021 end-page: 831 article-title: Sociodemographic index and global trends in prostate cancer: 1990–2017 publication-title: Prostate – volume: 86 start-page: 95 issue: 1 year: 2010 end-page: 102 article-title: Meat products and consumption culture in the East publication-title: Meat Sci – volume: 18 start-page: 177 issue: 1 year: 2018 article-title: Predictive significance of TMRPSS2‐ERG fusion in prostate cancer: a meta‐analysis publication-title: Cancer Cell Int – volume: 92 start-page: 241 issue: 2 year: 2005 end-page: 245 article-title: Years of life lost (YLL) from cancer is an important measure of population burden — and should be considered when allocating research funds publication-title: Br J Cancer – volume: 111 start-page: 1014 issue: 5 year: 2014 end-page: 1020 article-title: Years of life lost as a measure of cancer burden on a national level publication-title: Br J Cancer – volume: 4 start-page: 486 issue: 4 year: 2011 end-page: 501 article-title: Body mass index, prostate cancer–specific mortality, and biochemical recurrence: a systematic review and meta‐analysis publication-title: Cancer Prev Res – volume: 48 start-page: 1367 issue: 4 year: 2019 end-page: 1376 article-title: Reflection on modern methods: years of life lost due to premature mortality—a versatile and comprehensive measure for monitoring non‐communicable disease mortality publication-title: Int J Epidemiol – year: 2021 article-title: Cancer statistics for the year 2020: an overview – volume: 22 start-page: 323 issue: 3 year: 2020 end-page: 329 article-title: High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection publication-title: Asian J Androl – start-page: 371 year: 1997 end-page: 373 – volume: 71 start-page: 489 issue: 5 year: 2011 end-page: 497 article-title: TMPRSS2–ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, African‐American and Japanese patients publication-title: Prostate – volume: 4 start-page: 2110 issue: 12 year: 2011 end-page: 2121 article-title: Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate‐specific antigen‐era: incidence and survival publication-title: Cancer Prev Res – volume: 71 start-page: 209 issue: 3 year: 2021 end-page: 249 article-title: Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – start-page: 1 year: 2018 end-page: 6 – volume: 144 start-page: 1941 issue: 8 year: 2019 end-page: 1953 article-title: Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods publication-title: Int J Cancer – volume: 97 start-page: 433 issue: 6 year: 2005 end-page: 438 article-title: Prostate cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screening round of a randomized trial publication-title: J Natl Cancer Inst – volume: 29 start-page: 3659 issue: 27 year: 2011 end-page: 3668 article-title: Common gene rearrangements in prostate cancer publication-title: J Clin Oncol – volume: 127 start-page: 4221 issue: 22 year: 2021 end-page: 4232 article-title: Presentation, patterns of care, and outcomes of patients with prostate cancer in sub‐Saharan Africa: a population‐based registry study publication-title: Cancer – volume: 13 issue: 16 year: 2021 article-title: Obesity as a risk factor for prostate cancer mortality: a systematic review and dose‐response meta‐analysis of 280,199 patients publication-title: Cancers – volume: 360 start-page: 1320 issue: 13 year: 2009 end-page: 1328 article-title: Screening and prostate‐cancer mortality in a randomized European study publication-title: N Engl J Med – volume: 186 start-page: 1352 issue: 12 year: 2017 end-page: 1361 article-title: TMPRSS2:ERG gene fusions in prostate cancer of West African men and a meta‐analysis of racial differences publication-title: Am J Epidemiol – volume: 65 start-page: 11779 issue: 24 year: 2005 end-page: 11784 article-title: A prospective study of meat and meat mutagens and prostate cancer risk publication-title: Cancer Res – volume: 77 start-page: 38 issue: 1 year: 2020 end-page: 52 article-title: Recent global patterns in prostate cancer incidence and mortality rates publication-title: Eur Urol – volume: 141 start-page: 1783 issue: 9 year: 2017 end-page: 1793 article-title: Association between age‐related reductions in testosterone and risk of prostate cancer—an analysis of patients' data with prostatic diseases publication-title: Int J Cancer – volume: 10 start-page: 799 issue: 5 year: 2019 end-page: 804 article-title: Aging and the cancer burden in Latin America and the Caribbean: Time to act publication-title: J Geriatric Oncol – volume: 192 start-page: 730 issue: 3 year: 2014 end-page: 736 article-title: High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer publication-title: J Urol – volume: 1 start-page: 322 year: 1990 end-page: 329 article-title: Years of potential life lost (YPLL)—what does it measure? publication-title: Epidemiology – volume: 386 start-page: 1395 issue: 10001 year: 2015 end-page: 1406 article-title: A global assessment of civil registration and vital statistics systems: monitoring data quality and progress publication-title: Lancet – ident: e_1_2_9_13_1 doi: 10.1200/JCO.2011.35.1916 – ident: e_1_2_9_16_1 doi: 10.1093/aje/kwx235 – ident: e_1_2_9_2_1 doi: 10.3322/caac.21660 – ident: e_1_2_9_6_1 doi: 10.1056/NEJMoa0810084 – ident: e_1_2_9_24_1 doi: 10.3390/cancers13164169 – start-page: 1 volume-title: Global cancer observatory: cancer today year: 2018 ident: e_1_2_9_4_1 – ident: e_1_2_9_10_1 doi: 10.1002/ijc.31937 – ident: e_1_2_9_17_1 doi: 10.1158/0008-5472.CAN-05-2191 – ident: e_1_2_9_15_1 doi: 10.1186/s12935-018-0672-2 – ident: e_1_2_9_27_1 doi: 10.1097/00001648-199007000-00012 – ident: e_1_2_9_5_1 doi: 10.1016/j.eururo.2019.08.005 – ident: e_1_2_9_9_1 doi: 10.1038/bjc.2014.364 – ident: e_1_2_9_12_1 doi: 10.1016/j.jgo.2019.02.014 – ident: e_1_2_9_18_1 doi: 10.1158/1940-6207.CAPR-11-0354 – ident: e_1_2_9_14_1 doi: 10.1002/pros.21265 – ident: e_1_2_9_3_1 doi: 10.1002/ijc.33588 – ident: e_1_2_9_11_1 doi: 10.1093/ije/dyy254 – ident: e_1_2_9_26_1 doi: 10.1016/j.juro.2014.04.017 – ident: e_1_2_9_28_1 doi: 10.1002/pros.24178 – ident: e_1_2_9_8_1 doi: 10.1038/sj.bjc.6602321 – ident: e_1_2_9_7_1 doi: 10.1093/jnci/dji065 – ident: e_1_2_9_23_1 doi: 10.1158/1940-6207.CAPR-10-0229 – start-page: 371 volume-title: Food, nutrition and the prevention of cancer: a global perspective year: 1997 ident: e_1_2_9_19_1 – ident: e_1_2_9_25_1 doi: 10.1002/cncr.33818 – ident: e_1_2_9_29_1 doi: 10.1016/S0140-6736(15)60171-4 – ident: e_1_2_9_21_1 doi: 10.1002/ijc.30882 – ident: e_1_2_9_22_1 doi: 10.4103/aja.aja_70_19 – ident: e_1_2_9_20_1 doi: 10.1016/j.meatsci.2010.04.026 |
| SSID | ssj0010002 |
| Score | 2.5324833 |
| Snippet | Background
Prostate cancer is an important cause of death worldwide. The number of years of life lost (YLL) due to prostate cancer is a metric of the toll of... Prostate cancer is an important cause of death worldwide. The number of years of life lost (YLL) due to prostate cancer is a metric of the toll of prostate... BackgroundProstate cancer is an important cause of death worldwide. The number of years of life lost (YLL) due to prostate cancer is a metric of the toll of... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1088 |
| SubjectTerms | Age Aged Caribbean Region - epidemiology epidemiology Humans Life Expectancy Life span Male Mortality Prostate cancer Prostatic Neoplasms - epidemiology years of life lost |
| Title | Current and projected number of years of life lost due to prostate cancer: A global study |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpros.24360 https://www.ncbi.nlm.nih.gov/pubmed/35468227 https://www.proquest.com/docview/2681047175 https://www.proquest.com/docview/2655561122 https://pubmed.ncbi.nlm.nih.gov/PMC9246888 |
| Volume | 82 |
| WOSCitedRecordID | wos000787675600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1097-0045 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0010002 issn: 0270-4137 databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEB_OOxFf_P6onkdEXxR6103aJhFfDnXxQc_j9GB9Kmk-cGFpZbsr-N87k3Z7LieC-BaYCU2TmcxMkvkNwHMhnCy1M2ktrU_RpTapLrlNrckoGjFcuhCLTciTEzWb6dMdeL3JhenxIcYDN9KMuF-Tgpu6O7oADcUNpjvkuSgxYN-jrCoMvfbenk3PP4y3CKTu8YxFZilu1nKEJ-VHF723DdIlL_PyY8nfndhohaY3_2_8t-DG4H2y415cbsOOb-7AtY_D_fpd-DrANTHTODYc0njH-rIhrA3sJypGR43FPHi2aLsVc2vPVi1xx-QkZkmOlq_YMevBRlhEsL0H59N3X968T4fiC6nFiC1LVQimzoracpy94I2XE-0KXgRv62BVXuhJbpSRaOCRJAL6ldbl1pc6lwZNnLgPu03b-IfAdKad01J7Qo8T0hklVRC1kKLISxvyBF5sVqCyAzI5FchYVD2mMq_oF6o4Vwk8G3m_93gcf-Ta3yxkNegkUgh6DW2xLBJ4OpJRm-iKxDS-XRNPQfVCJ5wn8KBf9_EzNFp0p2QCcksiRgZC6t6mNPNvEbEbg9xSKZXAyygRfxl5dXr26XNsPfoX5sdwnVNeRnyZuA-7q-XaP4Gr9sdq3i0P4IqcqYNBO34BUpITvA |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3raxQxEB_kKuoX39rVqhH9orB2L9ndJP1W1KPi9Sy1hfbTks2DHhy7co9C_3sz2XTboyKI3wIzy-Yxk3kk-Q3Ae8YML6VRac21Tb1LrVJZUp1qlWE0oig3LhSb4JOJODmRB_FuDr6F6fAh-oQbakbYr1HBMSG9fYUa6neYxSeas9JH7Bt5ybgYwMaXw9HxuD9GQH0PSRaepX635j0-Kd2--nrdIt1wM2_elrzuxQYzNHrwnwN4CPej_0l2O4F5BLds8xju7McT9idwGgGbiGoMiWkaa0hXOIS0jlx41VhgYzZ1lszaxZKYlSXLFrnD8ySiUZLmO2SXdHAjJGDYPoXj0dejz3tpLL-Qah-zZalwTtVZUWvqp89ZZflQmoIWzuraaZEXcpgrobg38Z7EnPcstcm1LWXOlTdy7BkMmraxm0BkJo2RXFrEj2PcKMGFYzXjrMhL7fIEPlwuQaUjNjmWyJhVHaoyrXAIVZirBN71vL86RI4_cm1drmQVtdJTEHzNW2NeJPC2J3t9wkMS1dh2hTwFVgwdUprA827h-99gb71DxRPgayLRMyBW9zqlmZ4FzG4f5pZCiAQ-BpH4S8-rg8MfP0Prxb8wv4G7e0f742r8bfL9Jdyj-Eoj3FPcgsFyvrKv4LY-X04X89dRSX4DRQsWxA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3raxQxEB_KtRS_aOtzba0R_aKwdi_Z3SR-K7aHYj2PaqF-WrJ54MGxW-4h-N-byaZbj4og_RaYWTaPmcwjyW8AXjFmeCmNSmuubepdapXKkupUqwyjEUW5caHYBB-PxcWFnMS7OfgWpsOH6BNuqBlhv0YFt5fGHV6jhvodZvGW5qz0EftmXsgiH8Dm8dno_LQ_RkB9D0kWnqV-t-Y9Pik9vP563SLdcDNv3pb804sNZmh075YD2IG70f8kR53A7MKGbe7D9ud4wv4AvkfAJqIaQ2KaxhrSFQ4hrSO_vGossDGbOktm7WJJzMqSZYvc4XkS0ShJ83fkiHRwIyRg2D6E89HJt_cf0lh-IdU-ZstS4Zyqs6LW1E-fs8ryoTQFLZzVtdPCz_gwV0Jxb-I9iTnvWWqTa1vKnCtv5NgjGDRtY58AkZk0RnJpET-OcaMEF47VjLMiL7XLE3h9tQSVjtjkWCJjVnWoyrTCIVRhrhJ42fNedogcf-Xav1rJKmqlpyD4mrfGvEjgRU_2-oSHJKqx7Qp5CqwYOqQ0gcfdwve_wd56h4onwNdEomdArO51SjP9ETC7fZhbCiESeBNE4h89ryZnX76G1tP_YX4O25PjUXX6cfxpD-5QfKQRrinuw2A5X9lnsKV_LqeL-UHUkd-xGhY_ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+and+projected+number+of+years+of+life+lost+due+to+prostate+cancer%3A+A+global+study&rft.jtitle=The+Prostate&rft.au=Withrow%2C+Diana&rft.au=Pilleron%2C+Sophie&rft.au=Nikita%2C+Nikita&rft.au=Ferlay%2C+Jacques&rft.date=2022-08-01&rft.eissn=1097-0045&rft.volume=82&rft.issue=11&rft.spage=1088&rft_id=info:doi/10.1002%2Fpros.24360&rft_id=info%3Apmid%2F35468227&rft.externalDocID=35468227 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-4137&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-4137&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-4137&client=summon |